acetaminophen has been researched along with clofibrate in 36 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (8.33) | 18.7374 |
1990's | 5 (13.89) | 18.2507 |
2000's | 15 (41.67) | 29.6817 |
2010's | 13 (36.11) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Strassburg, CP; Tukey, RH | 1 |
Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Glen, RC; Lowe, R; Mitchell, JB | 1 |
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Calder, IC; Nicholls-Grzemski, FA; Priestly, BG | 1 |
Flower, R; Gryglewski, R; Herbaczyńska-Cedro, K; Vane, JR | 1 |
Vargaftig, BB; Zirinis, P | 1 |
Miller, M; Moses, AM | 1 |
Cohen, SD; Hart, SG; Hoivik, DJ; Khairallah, EA; Manautou, JE; Tveit, A | 1 |
Cohen, SD; Emeigh Hart, SG; Khairallah, EA; Manautou, JE | 1 |
Cohen, SD; Hoivik, DJ; Khairallah, EA; Manautou, JE; Tveit, A | 1 |
Carbone, JM; Chen, C; Hennig, GE; Manautou, JE; Nguyen, KA; Silva, VM; Whiteley, HE | 1 |
Burcham, PC; Calder, IC; Nicholls-Grzemski, FA; Priestly, BG | 1 |
Mehendale, HM | 1 |
Chen, C; Corton, JC; Hennig, GE; Manautou, JE; Whiteley, HE | 1 |
Cunningham, MJ; Fuhrman, S; Liang, S; Seilhamer, JJ; Somogyi, R | 1 |
Chen, C; Hennig, GE; Manautou, JE; McCann, DJ | 1 |
Chen, C; Hennig, GE; Manautou, JE; Whiteley, HE | 1 |
Aleksunes, LM; Kardas, MJ; Klaassen, CD; Manautou, JE; Moffit, JS; Slitt, AL | 1 |
Beger, RD; Holland, RD; Koza-Taylor, PH; Lawton, MP; Manautou, JE; Moffit, JS; Thibodeau, MS | 1 |
Fukuyama, T; Ikari, A; Ikushiro, S; Miwa, M; Osabe, M; Sugatani, J | 1 |
Hirabayashi, Y; Horii, I; Inoue, T; Kobayashi, K; Matsushita, T; Suzuki, H | 1 |
Bhave, VS; Donthamsetty, S; Latendresse, JR; Mehendale, HM; Mitra, MS | 1 |
Ando, Y; Kiyosawa, N; Manabe, S; Niino, N; Watanabe, K; Yamoto, T | 1 |
Eghbal, MA; Garjani, A; Ghaffarzadeh, M; Hamzeiy, H; Heidari, R; Nafisi, S; Ziaee, M | 1 |
Chasson, L; Ferreira, DW; Galland, F; Goedken, MJ; Manautou, JE; Naquet, P; Rommelaere, S | 1 |
4 review(s) available for acetaminophen and clofibrate
Article | Year |
---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Drug-induced dilutional hyponatremia.
Topics: Acetaminophen; Amitriptyline; Animals; Anura; Body Fluids; Carbamazepine; Chlorpropamide; Clofibrate; Cyclophosphamide; Diabetes Insipidus; Diabetes Mellitus; Diazoxide; Drug-Related Side Effects and Adverse Reactions; Humans; Hypoglycemic Agents; Hyponatremia; Kidney; Rats; Sodium; Sulfonylurea Compounds; Tolbutamide; Urinary Bladder; Vasopressins; Vincristine; Water Intoxication; Water-Electrolyte Balance | 1974 |
PPAR-alpha: a key to the mechanism of hepatoprotection by clofibrate.
Topics: Acetaminophen; Animals; Chemical and Drug Induced Liver Injury; Clofibrate; Drug Resistance; Hypolipidemic Agents; Liver; Mice; Peroxisome Proliferators; Peroxisomes; Rats; Receptors, Cytoplasmic and Nuclear; Transcription Factors | 2000 |
32 other study(ies) available for acetaminophen and clofibrate
Article | Year |
---|---|
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Peroxisome proliferators protect against paracetamol hepatotoxicity in mice.
Topics: 2,4,5-Trichlorophenoxyacetic Acid; Acetaminophen; Alanine Transaminase; Animals; Benzoquinones; Clofibrate; Diethylhexyl Phthalate; Glutathione; Imines; L-Iditol 2-Dehydrogenase; L-Lactate Dehydrogenase; Liver; Male; Mice; Microbodies; Oxidation-Reduction | 1992 |
Effects of anti-inflammatory drugs on prostaglandin biosynthesis.
Topics: Acetaminophen; Aldosterone; Animals; Anti-Inflammatory Agents; Aspirin; Azathioprine; Benzoates; Biological Assay; Clofibrate; Dexamethasone; Dogs; Edema; Fludrocortisone; Hydrocortisone; In Vitro Techniques; Indomethacin; Mefenamic Acid; Oxygenases; Phenylbutazone; Prostaglandins; Rats; Spleen; Triamcinolone Acetonide | 1972 |
Platelet aggregation induced by arachidonic acid is accompanied by release of potential inflammatory mediators distinct from PGE2 and PGF2.
Topics: Acetaminophen; Anti-Inflammatory Agents; Aorta; Arachidonic Acids; Aspirin; Biological Assay; Blood Platelets; Clofibrate; Glycerol; Indomethacin; Inflammation; Phenylbutazone; Platelet Adhesiveness; Prostaglandins; Tissue Extracts; Vasoconstrictor Agents | 1973 |
Clofibrate pretreatment diminishes acetaminophen's selective covalent binding and hepatotoxicity.
Topics: Acetaminophen; Analysis of Variance; Animals; Blotting, Western; Carrier Proteins; Clofibrate; Cytochrome P-450 Enzyme System; Glutathione; Liver; Male; Mice; Mice, Inbred ICR; Mice, Inbred Strains; Microbodies; Necrosis; Protein Binding; Sulfhydryl Compounds | 1994 |
Protection against acetaminophen hepatotoxicity by a single dose of clofibrate: effects on selective protein arylation and glutathione depletion.
Topics: Acetaminophen; Administration, Oral; Analgesics, Non-Narcotic; Animals; Clofibrate; Corn Oil; Cytosol; Glutathione; Hypolipidemic Agents; L-Iditol 2-Dehydrogenase; Liver; Liver Cirrhosis, Experimental; Male; Mice; Proteins; Staining and Labeling; Sulfhydryl Compounds | 1996 |
Protection by clofibrate against acetaminophen hepatotoxicity in male CD-1 mice is associated with an early increase in biliary concentration of acetaminophen-glutathione adducts.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Animals; Biliary Tract; Chromatography, High Pressure Liquid; Clofibrate; Glutamate-Cysteine Ligase; Glutathione; Hypolipidemic Agents; Male; Mice; Microsomes, Liver; Sulfhydryl Compounds | 1996 |
The PPAR activator docosahexaenoic acid prevents acetaminophen hepatotoxicity in male CD-1 mice.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Animals; Anticholesteremic Agents; Biotransformation; Blotting, Western; Chemical and Drug Induced Liver Injury; Clofibrate; Cytochrome P-450 CYP4A; Cytochrome P-450 Enzyme System; Docosahexaenoic Acids; Glucuronates; Liver; Liver Function Tests; Male; Mice; Mice, Inbred Strains; Microsomes, Liver; Mixed Function Oxygenases; Organ Size; Palmitoyl Coenzyme A; Receptors, Cytoplasmic and Nuclear; Succinate Dehydrogenase; Sulfhydryl Compounds; Transcription Factors | 1999 |
Clofibrate-induced in vitro hepatoprotection against acetaminophen is not due to altered glutathione homeostasis.
Topics: Acetaminophen; Animals; Antidotes; Cell Survival; Cells, Cultured; Chemical and Drug Induced Liver Injury; Clofibrate; Dose-Response Relationship, Drug; Drug Antagonism; Glutathione; Homeostasis; L-Iditol 2-Dehydrogenase; L-Lactate Dehydrogenase; Liver; Male; Maleates; Mice; Peroxisome Proliferators | 2000 |
Peroxisome proliferator-activated receptor alpha-null mice lack resistance to acetaminophen hepatotoxicity following clofibrate exposure.
Topics: Acetaminophen; Administration, Oral; Analgesics; Animals; Chemical and Drug Induced Liver Injury; Clofibrate; Female; Glutathione; Homozygote; Hypolipidemic Agents; Immunoenzyme Techniques; Injections, Intraperitoneal; L-Iditol 2-Dehydrogenase; Liver; Mice; Mice, Knockout; Necrosis; Organ Size; Receptors, Cytoplasmic and Nuclear; Transcription Factors | 2000 |
Gene expression microarray data analysis for toxicology profiling.
Topics: Acetaminophen; Animals; Benzo(a)pyrene; Clofibrate; Drug-Related Side Effects and Adverse Reactions; Entropy; Gene Expression; Gene Expression Profiling; Liver; Male; Oligonucleotide Array Sequence Analysis; Organ Size; Rats; Rats, Sprague-Dawley; RNA, Messenger; Toxicity Tests | 2000 |
Effects of clofibrate and indocyanine green on the hepatobiliary disposition of acetaminophen and its metabolites in male CD-1 mice.
Topics: Acetaminophen; Acetylcysteine; Analgesics, Non-Narcotic; Animals; Anions; Anticholesteremic Agents; Bile Ducts; Chromatography, High Pressure Liquid; Clofibrate; Coloring Agents; Drug Interactions; Glucuronides; Indocyanine Green; Liver; Male; Mice; Time Factors | 2000 |
Protection against acetaminophen hepatotoxicity by clofibrate pretreatment: role of catalase induction.
Topics: Acetaminophen; Administration, Oral; Amitrole; Analgesics, Non-Narcotic; Animals; Bile; Catalase; Chemical and Drug Induced Liver Injury; Chromatography, High Pressure Liquid; Clofibrate; Enzyme Induction; Enzyme Inhibitors; Injections, Intraperitoneal; Liver; Mice; Mice, Inbred ICR; Necrosis; Peroxisome Proliferators | 2002 |
Role of NAD(P)H:quinone oxidoreductase 1 in clofibrate-mediated hepatoprotection from acetaminophen.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Animals; Benzoquinones; Blotting, Western; Chemical and Drug Induced Liver Injury; Clofibrate; Drug Interactions; Enzyme Inhibitors; Hepatocytes; Imines; Indolequinones; L-Lactate Dehydrogenase; Male; Mice; Microsomes, Liver; NAD(P)H Dehydrogenase (Quinone); Peroxisome Proliferators | 2007 |
Differential gene expression in mouse liver associated with the hepatoprotective effect of clofibrate.
Topics: Acetaminophen; Acyl-CoA Oxidase; Amidohydrolases; Animals; Anticholesteremic Agents; Cell Adhesion Molecules; Chemical and Drug Induced Liver Injury; Clofibrate; Cluster Analysis; Cystamine; Cysteamine; Enoyl-CoA Hydratase; Gene Expression Profiling; GPI-Linked Proteins; Liver; Liver Diseases; Malate Dehydrogenase; Male; Mice; Mice, Inbred Strains; Mice, Knockout; Oligonucleotide Array Sequence Analysis; Pantetheine; Pantothenic Acid; Peroxisome Proliferators; PPAR alpha; Proteasome Endopeptidase Complex; Reverse Transcriptase Polymerase Chain Reaction | 2007 |
Expression of hepatic UDP-glucuronosyltransferase 1A1 and 1A6 correlated with increased expression of the nuclear constitutive androstane receptor and peroxisome proliferator-activated receptor alpha in male rats fed a high-fat and high-sucrose diet.
Topics: Acetaminophen; Animals; Clofibrate; Constitutive Androstane Receptor; Cytochrome P-450 Enzyme System; Dietary Fats; Dietary Sucrose; Female; Glucuronosyltransferase; Jejunum; Liver; Male; Microsomes, Liver; Organic Anion Transporters; Phenanthrolines; Phenobarbital; PPAR alpha; Rats; Rats, Wistar; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Transcription Factors | 2008 |
In vitro gene expression analysis of hepatotoxic drugs in rat primary hepatocytes.
Topics: Acetaminophen; Animals; Cell Culture Techniques; Cells, Cultured; Clofibrate; Cluster Analysis; Dose-Response Relationship, Drug; Feasibility Studies; Gene Expression Profiling; Hepatocytes; Male; Oligonucleotide Array Sequence Analysis; Rats; Rats, Sprague-Dawley; RNA, Messenger; Time Factors; Toxicity Tests; Transcription, Genetic | 2008 |
Nonalcoholic steatohepatitic (NASH) mice are protected from higher hepatotoxicity of acetaminophen upon induction of PPARalpha with clofibrate.
Topics: Acetaminophen; Adenosine Triphosphate; Alanine Transaminase; Animals; Clofibrate; Cytochrome P-450 CYP2E1; Cytoprotection; DNA Replication; Fatty Liver; Liver; Male; Mice; Oxidative Stress; PPAR alpha; Proliferating Cell Nuclear Antigen | 2008 |
Scoring multiple toxicological endpoints using a toxicogenomic database.
Topics: 2-Acetylaminofluorene; Acetaminophen; Algorithms; Animals; Biomarkers; Clofibrate; Data Interpretation, Statistical; Databases, Genetic; Endpoint Determination; Gene Expression; Liver; Male; Oligonucleotide Array Sequence Analysis; Phenobarbital; Rats; Rats, Sprague-Dawley; Toxicity Tests; Toxicogenetics | 2009 |
Cytoprotective effects of silafibrate, a newly-synthesised siliconated derivative of clofibrate, against acetaminophen-induced toxicity in isolated rat hepatocytes.
Topics: Acetaminophen; Animals; Anti-Inflammatory Agents, Non-Steroidal; Chemical and Drug Induced Liver Injury; Clofibrate; Cytoprotection; Hepatocytes; Male; Rats; Rats, Sprague-Dawley | 2014 |
Enhanced hepatotoxicity by acetaminophen in Vanin-1 knockout mice is associated with deficient proliferative and immune responses.
Topics: Acetaminophen; Amidohydrolases; Animals; Cell Proliferation; Chemical and Drug Induced Liver Injury; Clofibrate; Gene Expression Regulation; GPI-Linked Proteins; Hepatocytes; Liver; Macrophages; Mice; Mice, Knockout; PPAR alpha | 2016 |